Estimating The Intrinsic Value Of Fukuda Denshi Co., Ltd. (TSE:6960)

Advertisement

Key Insights

  • The projected fair value for Fukuda Denshi is JP¥7,070 based on 2 Stage Free Cash Flow to Equity
  • With JP¥6,710 share price, Fukuda Denshi appears to be trading close to its estimated fair value
  • Peers of Fukuda Denshi are currently trading on average at a 33% premium

Does the March share price for Fukuda Denshi Co., Ltd. (TSE:6960) reflect what it's really worth? Today, we will estimate the stock's intrinsic value by estimating the company's future cash flows and discounting them to their present value. We will take advantage of the Discounted Cash Flow (DCF) model for this purpose. Believe it or not, it's not too difficult to follow, as you'll see from our example!

Remember though, that there are many ways to estimate a company's value, and a DCF is just one method. Anyone interested in learning a bit more about intrinsic value should have a read of the Simply Wall St analysis model.

Check out our latest analysis for Fukuda Denshi

The Model

We use what is known as a 2-stage model, which simply means we have two different periods of growth rates for the company's cash flows. Generally the first stage is higher growth, and the second stage is a lower growth phase. To start off with, we need to estimate the next ten years of cash flows. Seeing as no analyst estimates of free cash flow are available to us, we have extrapolate the previous free cash flow (FCF) from the company's last reported value. We assume companies with shrinking free cash flow will slow their rate of shrinkage, and that companies with growing free cash flow will see their growth rate slow, over this period. We do this to reflect that growth tends to slow more in the early years than it does in later years.

A DCF is all about the idea that a dollar in the future is less valuable than a dollar today, so we need to discount the sum of these future cash flows to arrive at a present value estimate:

10-year free cash flow (FCF) forecast

2024202520262027202820292030203120322033
Levered FCF (¥, Millions) JP¥9.67bJP¥9.97bJP¥10.2bJP¥10.4bJP¥10.5bJP¥10.6bJP¥10.7bJP¥10.7bJP¥10.7bJP¥10.8b
Growth Rate Estimate SourceEst @ 4.45%Est @ 3.16%Est @ 2.26%Est @ 1.63%Est @ 1.19%Est @ 0.88%Est @ 0.66%Est @ 0.51%Est @ 0.41%Est @ 0.33%
Present Value (¥, Millions) Discounted @ 5.3% JP¥9.2kJP¥9.0kJP¥8.7kJP¥8.4kJP¥8.1kJP¥7.8kJP¥7.4kJP¥7.1kJP¥6.7kJP¥6.4k

("Est" = FCF growth rate estimated by Simply Wall St)
Present Value of 10-year Cash Flow (PVCF) = JP¥79b

After calculating the present value of future cash flows in the initial 10-year period, we need to calculate the Terminal Value, which accounts for all future cash flows beyond the first stage. The Gordon Growth formula is used to calculate Terminal Value at a future annual growth rate equal to the 5-year average of the 10-year government bond yield of 0.2%. We discount the terminal cash flows to today's value at a cost of equity of 5.3%.

Terminal Value (TV)= FCF2033 × (1 + g) ÷ (r – g) = JP¥11b× (1 + 0.2%) ÷ (5.3%– 0.2%) = JP¥210b

Present Value of Terminal Value (PVTV)= TV / (1 + r)10= JP¥210b÷ ( 1 + 5.3%)10= JP¥125b

The total value is the sum of cash flows for the next ten years plus the discounted terminal value, which results in the Total Equity Value, which in this case is JP¥204b. In the final step we divide the equity value by the number of shares outstanding. Relative to the current share price of JP¥6.7k, the company appears about fair value at a 5.1% discount to where the stock price trades currently. The assumptions in any calculation have a big impact on the valuation, so it is better to view this as a rough estimate, not precise down to the last cent.

dcf
TSE:6960 Discounted Cash Flow March 7th 2024

The Assumptions

The calculation above is very dependent on two assumptions. The first is the discount rate and the other is the cash flows. If you don't agree with these result, have a go at the calculation yourself and play with the assumptions. The DCF also does not consider the possible cyclicality of an industry, or a company's future capital requirements, so it does not give a full picture of a company's potential performance. Given that we are looking at Fukuda Denshi as potential shareholders, the cost of equity is used as the discount rate, rather than the cost of capital (or weighted average cost of capital, WACC) which accounts for debt. In this calculation we've used 5.3%, which is based on a levered beta of 0.915. Beta is a measure of a stock's volatility, compared to the market as a whole. We get our beta from the industry average beta of globally comparable companies, with an imposed limit between 0.8 and 2.0, which is a reasonable range for a stable business.

SWOT Analysis for Fukuda Denshi

Strength
  • Earnings growth over the past year exceeded the industry.
  • Debt is not viewed as a risk.
  • Dividends are covered by earnings and cash flows.
Weakness
  • Dividend is low compared to the top 25% of dividend payers in the Medical Equipment market.
Opportunity
  • Current share price is below our estimate of fair value.
  • Lack of analyst coverage makes it difficult to determine 6960's earnings prospects.
Threat
  • No apparent threats visible for 6960.

Looking Ahead:

Valuation is only one side of the coin in terms of building your investment thesis, and it ideally won't be the sole piece of analysis you scrutinize for a company. The DCF model is not a perfect stock valuation tool. Preferably you'd apply different cases and assumptions and see how they would impact the company's valuation. For example, changes in the company's cost of equity or the risk free rate can significantly impact the valuation. For Fukuda Denshi, we've put together three important elements you should further research:

  1. Risks: You should be aware of the 1 warning sign for Fukuda Denshi we've uncovered before considering an investment in the company.
  2. Other Solid Businesses: Low debt, high returns on equity and good past performance are fundamental to a strong business. Why not explore our interactive list of stocks with solid business fundamentals to see if there are other companies you may not have considered!
  3. Other Environmentally-Friendly Companies: Concerned about the environment and think consumers will buy eco-friendly products more and more? Browse through our interactive list of companies that are thinking about a greener future to discover some stocks you may not have thought of!

PS. Simply Wall St updates its DCF calculation for every Japanese stock every day, so if you want to find the intrinsic value of any other stock just search here.

New: AI Stock Screener & Alerts

Our new AI Stock Screener scans the market every day to uncover opportunities.

• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies

Or build your own from over 50 metrics.

Explore Now for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

About TSE:6960

Fukuda Denshi

Engages in the manufacture and sale of medical instruments in Japan and internationally.

Flawless balance sheet with proven track record.

Advertisement

Weekly Picks

LO
Lou_Basenese
GANX logo
Lou_Basenese on Gain Therapeutics ·

The Market Is Sleeping on This Parkinson's Biotech - And I Think That's a Mistake

Fair Value:US$7.675.1% undervalued
13 users have followed this narrative
0 users have commented on this narrative
12 users have liked this narrative
KI
NVDA logo
Kingman1152 on NVIDIA ·

NVIDIA will see a profit margin surge of 55% in the next 5 years

Fair Value:US$305.2535.6% undervalued
30 users have followed this narrative
0 users have commented on this narrative
10 users have liked this narrative
TE
BUSER logo
TechMegaTrends on Bambuser ·

Bambuser is today the only listed company in Europe that simultaneously possesses an 85% gross margin, proprietary AI infrastructure for the

Fair Value:SEK 238.2690.3% undervalued
14 users have followed this narrative
0 users have commented on this narrative
11 users have liked this narrative
HE
HedgeY
CSTM logo
HedgeY on Constellium ·

Constellium jet another cyclical aluminum processor, or a mispriced aluminum platform?

Fair Value:US$3410.2% undervalued
3 users have followed this narrative
0 users have commented on this narrative
2 users have liked this narrative

Updated Narratives

GO
NLBR logo
GoranLagea on Nova Ljubljanska Banka d.d ·

Nova Ljubljanska Banka d.d. future looks bright with a profit margin change of 38%

Fair Value:€36035.3% undervalued
5 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
AN
ELRIDGE logo
Anthony_Lee on Elridge Energy Holdings Berhad ·

Elridge Sees Quiet Accumulation as Urusharta Builds Position

Fair Value:RM 1.4537.9% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
AL
alexbarongo
CRDB logo
alexbarongo on CRDB Bank ·

Critical analysis of CRDB Bank Tanzania (DSE: CRDB).CRDB Bank Tanzania — Critical Investment Analysis

Fair Value:TSh2.59k15.0% overvalued
0 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

TR
tripledub
MSFT logo
tripledub on Microsoft ·

Everyone's Terrified Microsoft Will Keep Spending. I'm Terrified They'll Stop.

Fair Value:US$3950.5% undervalued
45 users have followed this narrative
3 users have commented on this narrative
42 users have liked this narrative
RO
Robbo
TSLA logo
Robbo on Tesla ·

The academically fascinating Tesla

Fair Value:US$301.1k% overvalued
38 users have followed this narrative
11 users have commented on this narrative
32 users have liked this narrative
AN
AnalystConsensusTarget
MSFT logo
AnalystConsensusTarget on Microsoft ·

Analyst Commentary Highlights Microsoft AI Momentum and Upward Valuation Amid Growth and Competitive Risks

Fair Value:US$587.3133.1% undervalued
1357 users have followed this narrative
2 users have commented on this narrative
11 users have liked this narrative